Morphologic characteristics of cutaneous immune-related adverse events in patients receiving immune checkpoint inhibitors combined with other anticancer therapies: A multicenter retrospective study (Supplemental File)
Published: 7 July 2022| Version 1 | DOI: 10.17632/ncsbbw5xjk.1
Contributors:
Maria Asdourian,
Ted Jacoby,
Nishi Shah,
Leah Thompson,
Tracey Otto,
Yevgeniy Semenov,
Nicole LeBoeuf,
Kerry Reynolds,
Anna Dewan,
Steven Chen
Description
This file includes additional methodological details and data.
Files
Categories
Dermatology, Oncology, Cancer Treatment, Chemotherapy, Adverse Event, Targeted Therapy, Medical Dermatology, Immune Checkpoint Blockade, Immune Checkpoint Inhibitor